International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

S Kumar, B Paiva, KC Anderson, B Durie… - The lancet …, 2016 - thelancet.com
Treatment of multiple myeloma has substantially changed over the past decade with the
introduction of several classes of new effective drugs that have greatly improved the rates …

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

S Kumar, B Paiva, KC Anderson, B Durie… - The lancet …, 2016 - scholarship.miami.edu
Abstract Antineoplastic Combined Chemotherapy Protocols-adverse effects Consensus
Humans Multiple Myeloma-drug therapy Neoplasm, Residual-chemically induced …

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

S Kumar, B Paiva, KC Anderson… - The Lancet …, 2016 - mayoclinic.elsevierpure.com
Abstract Treatment of multiple myeloma has substantially changed over the past decade
with the introduction of several classes of new effective drugs that have greatly improved the …

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

S Kumar, B Paiva, KC Anderson, B Durie… - THE LANCET …, 2016 - cris.unibo.it
Treatment of multiple myeloma has substantially changed over the past decade with the
introduction of several classes of new effective drugs that have greatly improved the rates …

[PDF][PDF] International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

S Kumar, B Paiva, KC Anderson, B Durie… - Lancet …, 2016 - minsight-mrd.com
Treatment of multiple myeloma has substantially changed over the past decade with the
introduction of several classes of new effective drugs that have greatly improved the rates …

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

S Kumar, B Paiva, KC Anderson, B Durie… - The Lancet …, 2016 - research.monash.edu
Abstract Treatment of multiple myeloma has substantially changed over the past decade
with the introduction of several classes of new effective drugs that have greatly improved the …

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

S Kumar, B Paiva, KC Anderson, B Durie… - The Lancet …, 2016 - Elsevier
Treatment of multiple myeloma has substantially changed over the past decade with the
introduction of several classes of new effective drugs that have greatly improved the rates …

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

S Kumar, B Paiva, KC Anderson, B Durie… - The Lancet …, 2016 - infona.pl
Treatment of multiple myeloma has substantially changed over the past decade with the
introduction of several classes of new effective drugs that have greatly improved the rates …

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

S Kumar, B Paiva, K Anderson, B Durie… - The Lancet …, 2016 - repub.eur.nl
Treatment of multiple myeloma has substantially changed over the past decade with the
introduction of several classes of new effective drugs that have greatly improved the rates …

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

S Kumar, B Paiva, KC Anderson, B Durie, O Landgren… - Lancet …, 2016 - vbn.aau.dk
Abstract Treatment of multiple myeloma has substantially changed over the past decade
with the introduction of several classes of new effective drugs that have greatly improved the …